Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage

Ramón Rodrigo1, Matías Libuy1, Felipe Feliú1

  • 1Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Independencia 1027, Casilla 70058, Santiago 7, Chile.

Disease Markers
|December 19, 2013
PubMed

Insights

Oxidative stress contributes to hypertension and ischemia/reperfusion injury. Validating biomarkers like F2-isoprostanes is crucial for understanding and treating these cardiovascular conditions.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Pathophysiology

Background:

  • Cardiovascular diseases, particularly hypertension, are major global health concerns.
  • Reactive oxygen and nitrogen species are implicated in hypertension and ischemia/reperfusion injury.
  • Validated biomarkers for oxidative stress in these conditions are still needed.

Purpose of the Study:

  • To explore the role of oxidative stress in hypertension and ischemia/reperfusion.
  • To investigate the association between oxidative stress biomarkers and clinical parameters.
  • To highlight the need for validated biomarkers in cardiovascular disease research.

Main Methods:

  • Correlation analysis of blood pressure with plasma F2-isoprostane levels and total antioxidant capacity.
  • Assessment of oxidative damage markers (lipid peroxidation, protein carbonylation) after cardiac surgery.
  • Review of emerging biomarkers including endothelial progenitor cells and ischemia modified albumin.

Main Results:

  • Positive correlation between blood pressure and plasma F2-isoprostane levels.
  • Negative correlation between blood pressure and plasma total antioxidant capacity.
  • Increased lipid peroxidation and protein carbonylation observed following cardiac surgery-induced ischemia/reperfusion.

Conclusions:

  • Oxidative stress is a key factor in essential hypertension and ischemia/reperfusion.
  • F2-isoprostanes and antioxidant capacity are potential biomarkers for hypertension.
  • Further validation of oxidative and nitrosative stress biomarkers is essential for clinical application.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
68
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886